FRE Fresenius SE & Co KGaA

   By Anthony Shevlin 
 

Fresenius SE (FRE.XE) raised its full-year sales guidance on Tuesday after a good second quarter.

The German health-care company said net profit before special items for the quarter were 480 million euros ($534.3 million), flat on the year prior at constant currency. Sales rose 6% to EUR8.8 billion, the company said.

Fresenius backed its earnings guidance for 2019 but raised its sales growth expectations. The company now sees growth at constant currency rates between 4% to 7%, having previously guided for growth between 3% to 6%.

Fresenius Medical Care AG (FME.XE)--the dialysis company majority-owned by Fresenius--backed its full-year guidance.

It reported second-quarter sales of EUR4.28 billion, compared with EUR3.96 billion the year previous.

Fresenius Medical Care said net income for the quarter was EUR279 million.

Write to Anthony Shevlin at anthony.shevlin@dowjones.com; @anthony_shevlin

(END) Dow Jones Newswires

July 30, 2019 01:28 ET (05:28 GMT)

Fresenius SE & Co KGaA (TG:FRE)
Historical Stock Chart
Von Mär 2024 bis Apr 2024

Fresenius SE & Co KGaA (TG:FRE)
Historical Stock Chart
Von Apr 2023 bis Apr 2024